EAPCI Column

DOI:

EAPCI Focus on the EAPCI Scientific Documents and Initiatives Committee

An interview with the Chair Giulio Stefanini

Figure 1

Figure 1.

What is the role of the committee?

Any proposal for scientific documents received by the EAPCI must be submitted to the Scientific Documents and Initiatives Committee (SDIC) for approval prior to their development. Together with my Co-Chair Nieves Gonzalo and committee members, the SDIC reviews all document proposals and makes approval or rejection recommendations. These recommendations are then reviewed and confirmed by the EAPCI Executive Committee. The responsibilities of the committee include the screening and validation of solicited and unsolicited documentation proposals as well as the identification of topics suitable for EAPCI scientific documents. Once the topic has been selected and approved, the committee is responsible for the administrative supervision and coordination of Writing Groups, coordination of the declarations of interest process for appointed authors as well as coordination of the review process.

How do EAPCI scientific documents benefit the community?

The key benefit of EAPCI scientific documents is to provide guidance for clinical management on topics not covered, or not covered in sufficient detail, in the existing or upcoming ESC Clinical Practice Guidelines. Whilst their topics and scope should not overlap with those of guidelines, scientific documents may complement them by providing more in-depth information in specific areas that cannot be expanded upon in guidelines. Our scientific documents evaluate scientific evidence, explore expert consensus in a structured way and, typically, include very practical advice for daily management of the topics discussed.

How are topics chosen and how can EAPCI members contribute?

Any EAPCI member may submit a proposal for a scientific document; any proposal received is subject to the robust and transparent review process of the SDIC followed by the EAPCI Executive Committee. Furthermore, one of the roles of the SDIC is to identify areas of unmet need and propose these topics to the EAPCI Executive Committee for consideration.

What are the upcoming topics?

  • Percutaneous coronary intervention in patients with cancer
  • Follow-up strategies in patients after transcatheter aortic valve replacement
  • Day-clinic care for percutaneous cardiovascular interventions
  • Sex-related considerations in mitral and tricuspid valve interventions

News

  • Attending ESC Congress 2023 in Amsterdam from August 25th-28th? Come to the ESC Plaza and find out more about EAPCI.
  • Not yet an EAPCI member? Join online https://www.escardio.org/EAPCI
Volume 19 Number 5
Aug 7, 2023
Volume 19 Number 5
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00052 Nov 18, 2024
Low-flow, low-gradient aortic stenosis: an understanding is still a long way off
Webb J and Offen S
free

Debate

10.4244/EIJ-E-24-00054 Nov 18, 2024
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons
Rodés-Cabau J et al
free

EAPCI Column

Nov 18, 2024
EAPCI at PCR London Valves 2024
free

Original Research

10.4244/EIJ-D-24-00442 Nov 18, 2024
Long-term survival after TAVI in low-flow, low-gradient aortic valve stenosis
Cardaioli F et al

Original Research

10.4244/EIJ-D-24-00367 Nov 18, 2024
Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study
Bieliauskas G et al
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved